Self-Reported Late Effects and Quality of Life (QOL) of Long-Term Survivors of Severe Aplastic Anemia Who Have Undergone Allogeneic Hematopoietic Cell Transplant (HCT)

With improved outcomes of patients who have undergone allogeneic HCT for severe aplastic anemia (SAA) there is a growing population of survivors. However, current literature lacks details regarding late effects that occur in these survivors. Additionally, with increasing use of alternative donors for SAA, it is important to compare their late effects and quality of life (QOL) by donor type.

Source: Biology of Blood and Marrow Transplantation - February 1, 2024 Category: Hematology Authors: Neel S. Bhatt, Lynn Onstad, Dr. Paul A. Carpenter, Catherine J. Lee, Rohtesh S. Mehta, Masumi Ueda, Phuong Vo, K. Scott Baker, Stephanie J. Lee Tags: 474 Source Type: research